Tuesday, May 12, 2015

FDA Panel Backs Vertex Cystic-Fibrosis Drug Orkambi

Vertex Pharmaceuticals’ experimental cystic fibrosis treatment Orkambi won the backing of an FDA advisory panel, which recommended approval.

from WSJ.com: US Business http://ift.tt/1QGRX4o
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)